Jyoti Malhotra, M.D., M.P.H.

Medical oncologist Jyoti Malhotra, M.D., M.P.H., centers her philosophy of care on learning as much as possible about each patient—what is important to them, the challenges they face, and the therapeutic approach they want to take—as well as the details of their disease. She aims to free them up to focus on healing while she and her colleagues take care of things such as navigating the system and keeping the care plan moving in the right direction.

In her capacity as director of thoracic medical oncology at the Lennar Foundation Cancer Center at City of Hope Orange County, she is excited about offering patients an expansive slate of early-phase clinical trials to offer more people access to new therapies. Dr. Malhotra’s expertise is in Experimental Therapeutics and she has led multiple phase I trials investigating novel agents and combinations for cancer therapy including first-in-human trials. She aims to bring together advances in precision medicine, which targets treatment to the molecular and genetic characteristics of each tumor, and immunotherapy, which harnesses the body’s natural defenses to fight cancer. Dr. Malhotra leads multiple investigator initiated clinical trials as well as a national trial sponsored by the National Cancer Institute- Cancer Therapy Evaluation Program (CTEP). She has authored more than 100 publications, book chapters and abstracts.

Dr. Malhotra earned her medical degree from Maulana Azad Medical College at the University of Delhi in India, and then a master’s from the Bloomberg School of Public Health at Johns Hopkins University. She was an internal medicine resident at Georgetown University/Washington Hospital Center and an oncology/hematology fellow at Mount Sinai Medical Center in New York. Her previous appointments were at Memorial Sloan Kettering Cancer Center, Mount Sinai, and, most recently, Rutgers Cancer Institute of New Jersey, where she was leader of the Phase I/Investigational Therapeutics program.

Fluent in Hindi, Dr. Malhotra dedicates her time away from cancer care and research to family, travel, and cooking.

Awards

• 2020, Program for Early Career Excellence (PECE), Rutgers University
• 2019, OASIS Leadership program, Rutgers University
• 2016, Young Investigator’s Forum in Non-Small Cell Lung Cancer
• 2015, Young Investigator Award, ASCO Conquer Cancer Foundation
• 2014, AACR-Millennium Scholar-in-Training Award
• 2011, ‘Stephen Shalet’ prize for best oral presentation at European Symposium on Late Complications after Childhood Cancer, Amsterdam
• 2008, Research poster winner in the National meeting of ACP, Washington DC
• 2007, 1st prize in oral research presentation at American College of Physicians’ (ACP) Meeting, Bethesda

Memberships

• 2019 – Present, Member, International Association for the Study of Lung Cancer (IASLC)
• 2018 – Present, Member, Society for Immunotherapy of Cancer (SITC)
• 2015 – Present, Member, American Association for Cancer Research (AACR)
• 2015 – Present, Member, American Society of Oncology (ASCO)
• 2014 – Present, Member, Molecular Epidemiology working group (AACR )
• 2013 – 2015, Associate Member, American Association for Cancer Research (AACR)
• 2012 – 2015, Associate Member, American Society of Oncology (ASCO)
• 2012 – 2015, Associate Member, American Society of Hematology
• 2011 – 2013, Member, NY Chapter American College of Physicians’ (ACP) Health and Public Policy Committee
• 2007 – 2013, Member, American College of Physicians (ACP)